Agios Pharmaceuticals AGIO Professional Service Fees Payable
Professional Service Fees Payable at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's professional service fees payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's professional service fees payable?
- Agios Pharmaceuticals (AGIO) reported professional service fees payable of $2.77M in Q1 2026.
- How has Agios Pharmaceuticals's professional service fees payable changed year-over-year?
- Agios Pharmaceuticals's professional service fees payable increased by 64.8% year-over-year, from $1.68M to $2.77M.
- What is the long-term trend for Agios Pharmaceuticals's professional service fees payable?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's professional service fees payable has grown at a 4.5% compound annual growth rate (CAGR), from $2.9M to $3.61M.